Literature DB >> 4037939

Factors influencing erythrocyte sedimentation in patients with chronic renal failure.

N Shusterman, P L Kimmel, F L Kiechle, S Williams, G Morrison, I Singer.   

Abstract

Erythrocyte sedimentation was studied in stable patients with chronic renal failure free of complicating illnesses. The mean (+/- SD) Westergren erythrocyte sedimentation rate was 49 +/- 26 mm/hr in patients not receiving dialysis and 60 +/- 33 mm/hr in patients receiving hemodialysis. Both values are significantly higher than normal. Because anemia accelerates the Westergren determination, we restudied the patients with the zeta sedimentation ratio (ZSR), a method unaffected by hematocrit. In nine patients not receiving dialysis and 49 patients receiving hemodialysis, the ZSR was significantly higher than normal. The ZSR correlated positively with plasma fibrinogen concentration. Recombination experiments showed that the abnormal factor accelerating erythrocyte sedimentation was a constituent of plasma. Thus, erythrocyte sedimentation is accelerated in stable patients with chronic renal failure and a plasma factor, probably fibrinogen, is responsible. An elevated erythrocyte sedimentation rate in this population lacks diagnostic usefulness.

Entities:  

Mesh:

Year:  1985        PMID: 4037939

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Erythrocyte sedimentation in nephrotic syndrome.

Authors:  S Eustace; E Campbell; J Fennell; J Donohoe
Journal:  Ir J Med Sci       Date:  1988-12       Impact factor: 1.568

2.  Inflammation and Its Determinants in Patients With Chronic Kidney Disease: A Study From North Eastern Region of India.

Authors:  Anamika Das; Bhupen Barman; Prasanta Bhattacharya; K G Lynrah; Iadarilang Tiewsoh; Pranjal Phukan
Journal:  Cureus       Date:  2022-01-04

3.  18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin.

Authors:  Karel-Jan D F Lensen; Alexandre E Voskuyl; Conny J van der Laken; Emile F I Comans; Dirkjan van Schaardenburg; Alex B Arntzenius; Ton Zwijnenburg; Frank Stam; Michelle Gompelman; Friso M V D Zant; Anneke Q A van Paassen; Bert J Voerman; Frits Smit; Sander Anten; Carl E Siegert; Arjen Binnerts; Yvo M Smulders
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

Review 4.  Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians.

Authors:  Anurag Markanday
Journal:  Open Forum Infect Dis       Date:  2015-07-03       Impact factor: 3.835

5.  Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.

Authors:  Michelle J Ormseth; Cecilia P Chung; Annette M Oeser; Margery A Connelly; Tuulikki Sokka; Paolo Raggi; Joseph F Solus; James D Otvos; C Michael Stein
Journal:  Arthritis Res Ther       Date:  2015-05-09       Impact factor: 5.156

6.  Decreased accuracy of erythrocyte sedimentation rate in diagnosing osteomyelitis in diabetic foot infection patients with severe renal impairment: A retrospective cross-sectional study.

Authors:  Xin Chen; Yiting Shen; Yuying Wang; Yang Li; Shuyu Guo; Yue Liang; Xuanyu Wang; Siyuan Zhou; Xiaojie Hu; Kaiwen Ma; Rui Tian; Wenting Fei; Yuqin Sheng; Hengjie Cao; Huafa Que
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.